Skip to main content

Peer Review reports

From: The place of S-ketamine in fibromyalgia treatment (ESKEFIB): study protocol for a prospective, single-center, double-blind, randomized, parallel-group, dose-escalation controlled trial

Original Submission
25 Dec 2020 Submitted Original manuscript
18 Sep 2021 Reviewed Reviewer Report - Alexander Gough
19 Sep 2021 Reviewed Reviewer Report - Thanan Elalingam
22 Oct 2021 Author responded Author comments - Zuzana Javorcikova
Resubmission - Version 2
22 Oct 2021 Submitted Manuscript version 2
1 Nov 2021 Reviewed Reviewer Report - Alexander Gough
9 Nov 2021 Reviewed Reviewer Report - Thanan Elalingam
Resubmission - Version 3
Submitted Manuscript version 3
Publishing
10 Nov 2021 Editorially accepted
27 Nov 2021 Article published 10.1186/s13063-021-05814-4

You can find further information about peer review here.

Back to article page